ReviewJournal of clinical medicine2025
AI-Powered Precision: Revolutionizing Atrial Fibrillation Detection with Electrocardiograms.
Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- AI-Driven Atrial Fibrillation Management: From Signal to Strategy.Balkan medical journal · 2026Review
- Artificial intelligence in pediatric arrhythmias: current landscape, unique challenges, and translational perspectives.Frontiers in pediatrics · 2026Review
- Artificial intelligence in cardiology: implications for healthcare outcomes.Frontiers in artificial intelligence · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial fibrillation (AF) is a common cardiac arrhythmia linked to an increased risk of stroke, heart failure, and mortality, yet its diagnosis remains challenging due to its intermittent and often asymptomatic nature. Traditional methods, such as standard electrocardiography (ECG) and prolonged cardiac monitoring, have limitations in terms of cost, accessibility, and diagnostic yield. Artificial intelligence (AI), particularly machine learning (ML) and deep learning, has emerged as a promising tool for AF detection and prediction by analyzing ECG data with high accuracy. AI models can identify subtle patterns in ECG signals that may indicate AF, even when the arrhythmia is not actively present, improving early diagnosis and risk stratification. Additionally, AI-powered ECG analysis has been integrated into wearable and mobile health devices, expanding screening capabilities beyond clinical settings. While studies have demonstrated AI's effectiveness, challenges such as data bias, model reliability across diverse populations, and regulatory considerations must be addressed before widespread clinical adoption. If these obstacles are overcome, AI has the potential to revolutionize AF management by enabling earlier detection, reducing the need for resource-intensive monitoring, and improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.